TheHill is looking to partner with companies that wish to submit a project proposal or are interested in our grant writing service for the following upcoming calls supporting preclinical and clinical development of medical technologies in areas of existing or emerging patient need advertised by NIHR Invention for Innovation (i4i) programme (Invention for Innovation | NIHR).
1st Call: Product Development Awards
The i4i Product Development Awards (PDA) supports translational research and development of medical devices, in vitro diagnostics and high-impact patient-focused digital health technologies for ultimate NHS use. The research proposals may address any disease or health area, provided there is a clear unmet clinical need. There is no upper funding limit for Product Development Awards, but costs must be fully justified.
Key eligibility criteria
- Projects can be led by small-to-medium-sized enterprises (SME), NHS providers or higher education institutions (HEIs).
- Projects must be collaborative between any two of the eligible types of organisation.
- Projects can last a minimum of 24 months and a maximum of 36 months.
- The lead organisation must be registered in England.
Deadline for the call: 10th of May 2022
Deadline for the request for support to TheHill: 20th of April 2022
2nd Call: Challenge Awards
i4i Challenge Awards support market-ready innovations by addressing the translational gap between the clinical evaluation of technologies and their adoption, by funding the assessment of MedTech innovations in real-world healthcare settings. The expected output is a disruptive medical device or in vitro diagnostic test that can offer improved outcomes for NHS patients. There is no upper funding limit for the Challenge Awards, but costs must be fully justified.
Key eligibility criteria
- Projects can be led by SMEs, NHS providers or higher education institutions (HEIs).
- A minimum of two organisations must be involved and at least one of the collaborators must be from an NHS provider (e.g. an NHS Trust).
- Technologies must have demonstrated safety and efficacy and must have obtained or be in the process of obtaining CE marking.
- Project timelines can vary based on the required evidence for potential healthcare uptake and patient benefit. They can last up to 3 years, but a duration of up to 5 years will be considered if a longer period is needed to demonstrate long-term outcomes and a strong case is made.
- Lead applicants must be based in England.
Deadline for the call: 2nd of June 2022
Deadline for the request for support to TheHill: 3rd of May 2022